InspireMD (NSPR) Current Deferred Tax Assets (2015 - 2016)
InspireMD's (NSPR) quarterly Current Deferred Tax Assets came in at $98000.0 in Q4 2016, down 45.25% year-on-year from $179000.0 in Q1 2016, and down 45.25% quarter-over-quarter from $179000.0 in Q4 2015.
InspireMD (NSPR) Current Deferred Tax Assets (2015 - 2016) Analysis & Trends
InspireMD's Current Deferred Tax Assets history runs 2 years deep, the most recent figure standing at $98000.0 for Q4 2016.
- On a quarterly basis, Current Deferred Tax Assets fell 45.25% year-over-year to $98000.0 in Q4 2016; TTM through Dec 2016 was $98000.0, a 45.25% decrease from a year earlier, with the FY2016 full-year figure at $98000.0, down 45.25% from the prior year.
- Current Deferred Tax Assets retreated to $98000.0 in Q4 2016 per NSPR's latest filing, from $179000.0 in the prior quarter.
- Across five years, Current Deferred Tax Assets topped out at $179000.0 in Q4 2015 and bottomed at $98000.0 in Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | InspireMD | 2,073.45 | -54.21 Mn | 1.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 98,000.00 |
| Dec 31, 2016 | 98,000.00 |
| Dec 31, 2015 | 179,000.00 |
| Dec 31, 2015 | 179,000.00 |